Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > latest news release

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon May 06, 2024 11:29am

158 Views

Post# 36024987

RE:RE:latest news release

I was just wondering what the newest Director on the TLT Borad is doing in terms of creating awareness for this Novel treatment using the PDT. Have not heard anything from DR.Kaouthar Lbiati since was invited to an independant director. She was appointed almost a year ago on 3rd June, 2023. Not a word from her, No mention in her Twitter "X" account as well of this exciting, potential cure that she is part of the Leadership team. Hopefully, she is working on a JV partner or increasing the clinical test sites behind the scenes that the TLT Management can not discuss openly?

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle